BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20020915)

  • 1. In Silico Screening of Chemicals for Genetic Toxicity Using MDL-QSAR, Nonparametric Discriminant Analysis, E-State, Connectivity, and Molecular Property Descriptors.
    Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
    Toxicol Mech Methods; 2008; 18(2-3):207-16. PubMed ID: 20020915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software.
    Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
    Regul Toxicol Pharmacol; 2005 Dec; 43(3):313-23. PubMed ID: 16242226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models.
    Contrera JF; Kruhlak NL; Matthews EJ; Benz RD
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):172-82. PubMed ID: 17703860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three new consensus QSAR models for the prediction of Ames genotoxicity.
    Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
    Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Kruhlak NL; Choi SS; Contrera JF; Weaver JL; Willard JM; Hastings KL; Sancilio LF
    Toxicol Mech Methods; 2008; 18(2-3):217-27. PubMed ID: 20020916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals.
    Matthews EJ; Kruhlak NL; Daniel Benz R; Ivanov J; Klopman G; Contrera JF
    Regul Toxicol Pharmacol; 2007 Mar; 47(2):136-55. PubMed ID: 17175082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose.
    Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):185-206. PubMed ID: 15546675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in Rodents.
    Matthews EJ; Kruhlak NL; Benz RD; Contrera JF; Marchant CA; Yang C
    Toxicol Mech Methods; 2008; 18(2-3):189-206. PubMed ID: 20020914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities.
    Contrera JF
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):133-41. PubMed ID: 20933038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices.
    Contrera JF; Matthews EJ; Daniel Benz R
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):243-59. PubMed ID: 14623477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial QSAR modeling of P-glycoprotein substrates.
    de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
    J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
    Liu Z; Kelly R; Fang H; Ding D; Tong W
    Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
    Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
    Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR models for anti-androgenic effect--a preliminary study.
    Jensen GE; Nikolov NG; Wedebye EB; Ringsted T; Niemela JR
    SAR QSAR Environ Res; 2011 Mar; 22(1-2):35-49. PubMed ID: 21391140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):97-110. PubMed ID: 16352383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.
    Su BH; Shen MY; Esposito EX; Hopfinger AJ; Tseng YJ
    J Chem Inf Model; 2010 Jul; 50(7):1304-18. PubMed ID: 20565102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.